The groundbreaking treatment of this peptide represents a major advance in the management of diabetes mellitus type 2. Unlike existing drugs, tirzepatide affects two pathways – GLP-1 and GIP – resulting in enhanced https://tirzepatidepeptide234798.bloggactif.com/43511814/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment